How to Be Considerate to Patients with Thyroid Nodules: Lessons from the Pediatric Thyroid Cancer Screening Program in Fukushima After the Nuclear Plant Accident

  • Sanae MidorikawaEmail author
  • Akira Ohtsuru


Overdiagnosis of thyroid cancer is considered to be a global problem [1–3]. Thus, the indication criteria for thyroid fine needle aspiration (FNA) cytology are also currently being debated [4, 5]. Standard indications for FNA cytology of thyroid nodules detected by ultrasound are described in some guidelines [5, 6] as well as in other chapters of this textbook. Notably, application of FNA cytology to incidentally detected thyroid nodules in asymptomatic patients should be very carefully considered because overdiagnosis of thyroid cancer can easily occur in mass screening, which tends to directly lead to overtreatment [2]. In this chapter, we focus on ultrasound screening of young asymptomatic patients and indications for FNA cytology of thyroid nodules, from the two perspectives of psychosocial impact and ethical issues, based on lessons learned from the experience of the Fukushima Health Management Survey (FHMS) conducted after the nuclear accident in Fukushima, Japan.


  1. 1.
    Ahn HS, Kim HJ, Welch HG. Korea’s thyroid-cancer “epidemic”—screening and overdiagnosis. N Engl J Med. 2014;371(19):1765–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Lin JS, Bowles EJA, Williams SB, Morrison CC. Screening for thyroid cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2017;318(18):1888–903.CrossRefGoogle Scholar
  3. 3.
    Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102(9):605–13.PubMedCrossRefGoogle Scholar
  4. 4.
    Cho YJ, Kim DY, Park EC, Han KT. Thyroid fine-needle aspiration biopsy positively correlates with increased diagnosis of thyroid cancer in South Korean patients. BMC Cancer. 2017;17(1):114.PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1–133.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Kitaoka M, Miyamoto Y, Fukunari N, et al. Ultrasound diagnostic criteria for thyroid nodule. Jpn J Med Ultrasonics. 2011;38(6):669–70.Google Scholar
  7. 7.
    Shimura H, Sobue T, Takahashi H, et al. Findings of thyroid ultrasound examination within 3 years after the fukushima nuclear power plant accident: the fukushima health management survey. J Clin Endocrinol Metab. 2018;103(3):861–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Midorikawa S, Tanigawa K, Suzuki S, Ohtsuru A. Psychosocial issues related to thyroid examination after a radiation disaster. Asia Pac J Public Health. 2017;29(2S):63S–73S.PubMedCrossRefGoogle Scholar
  9. 9.
    Midorikawa S, Suzuki S, Ohtsuru A. After fukushima: addressing anxiety. Science. 2016;352(6286):666–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Suzuki S, Yamashita S, Fukushima T, Nakano K, Midorikawa S, Ohtsuru A, Yasumura S, Hosoya M, Kamiya K, Shimura H, Suzuki S. The protocol and preliminary baseline survey results of the thyroid ultrasound examination in Fukushima [Rapid Communication]. Endocr J. 2016;63(3):315–21.PubMedCrossRefGoogle Scholar
  11. 11.
    Midorikawa S, Ohtsuru A, Suzuki S, et al. Psychosocial impact on the thyroid examination of the Fukushima health management survey. In: Yamashita S, Thomas G, editors. Thyroid cancer and nuclear accidents: long-term after-effects of Chernobyl and Fukushima. 1st ed. Elsevier: Academic Press; 2017.Google Scholar
  12. 12.
    Murakami M, Takebayashi Y, Takeda Y, et al. Effect of radiological countermeasures on subjective well-being and radiation anxiety after the 2011 disaster: the Fukushima health management survey. Int J Environ Res Public Health. 2018;15(1):pii: E124. Scholar
  13. 13.
    Bibbins-Domingo K, Grossman DC, Curry SJ, Barry MJ, Davidson KW, Doubeni CA, Epling JW Jr, Kemper AR, Krist AH, Kurth AE, Landefeld CS, Mangione CM, Phipps MG, Silverstein M, Simon MA, Siu AL, Tseng CW. Screening for thyroid cancer: US preventive services task force recommendation statement. JAMA. 2017;317(18):1882–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Kananoda K, Kama K, Tsugane S. Quantification of the increase in thyroid cancer prevalence in Fukushima after the nuclear disaster in 2011—a potential overdiagnosis? Jpn J Clin Oncol. 2016;46(3):284–6.CrossRefGoogle Scholar
  15. 15.
    Ohtsuru A, Midorikawa S, Suzuki S, Shimura H, Matsuzuka T, Yamashita S. Five-year interim report of thyroid ultrasound examinations in the Fukushima health management survey. In: Yamashita S, Thomas G, editors. Thyroid cancer and nuclear accidents: long-term after-effects of Chernobyl and Fukushima. 1st ed. Elsevier: Academic Press; 2017.Google Scholar
  16. 16.
    Furuya-Kanamori L, Bell KJ, Clark J, Glasziou P, Doi SA. Prevalence of differentiated thyroid cancer in autopsy studies over six decades: a meta-analysis. J Clin Oncol. 2016;34(30):3672–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Valle LA, Kloos RT. The prevalence of occult medullary thyroid carcinoma at autopsy. J Clin Endocrinol Metab. 2011;96(1):E109–13.PubMedCrossRefGoogle Scholar
  18. 18.
    Miyauchi A. Clinical trials of active surveillance of papillary microcarcinoma of the thyroid. World J Surg. 2016;40(3):516–22.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Sugitani I, Toda K, Yamada K, Yamamoto N, Ikenaga M, Fujimoto Y. Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg. 2011;34(6):1222–31.CrossRefGoogle Scholar
  20. 20.
    Midorikawa S, Ohtsuru A, Murakami M, et al. Comparative analysis of the growth pattern of thyroid cancer in young patients screened by ultrasonography in Japan after a nuclear accident. The Fukushima health management survey. JAMA Otolaryngol Head Neck Surg. 2018;144(1):57–63.PubMedGoogle Scholar
  21. 21.
    Takahashi H, Takahashi K, Shimura H, et al. Simulation of expected childhood and adolescent thyroid cancer cases in Japan using a cancer progression model based on the National Cancer Registry. Medicine (Baltimore). 2017;96(48):e8631.CrossRefGoogle Scholar
  22. 22.
    Manning SC. Rethinking the growth pattern of thyroid cancer in young patients based on the Fukushima database. JAMA Otolaryngol Head Neck Surg. 2018;144(1):63–4.Google Scholar
  23. 23.
    Kahana SY, Feeny NC, Youngstrom EA, Drotar D. Posttraumatic stress in youth experiencing illnesses and injuries: an exploratory meta-analysis. Traumatology. 2006;12(2):148–61.CrossRefGoogle Scholar
  24. 24.
    Meentken MG, Beynum IM, Legerstee JS, Helbing WA, Utens EMWJ. Medically related post-traumatic stress in children and adolescents with congenital heart defects. Front Pediatr. 2017;5:1–6.CrossRefGoogle Scholar
  25. 25.
    Boyer BA, Matour SJ, Crittenden KB, Larson KA, Cox JM, Link DD. Appraisals of fear, helplessness, and perceived life-threat during emergent cardiac surgery: relationship to pre-surgical depression, trauma history, and posttraumatic stress. J Clin Psychol Med Settings. 2013;20(2):173–85.PubMedCrossRefGoogle Scholar
  26. 26.
    Kassam-Adams N. Introduction to the special issue. Posttraumatic stress related to pediatric illness and injury. J Pediatr Psychol. 2006;31(4):337–42.PubMedCrossRefGoogle Scholar
  27. 27.
    Marsac ML, Cirilli C, Kassam-Adams N, Winston FK. Post-injury medical and psychosocial care in children: impact of traumatic stress symptoms. Child Health Care. 2011;40(2):116–29.CrossRefGoogle Scholar
  28. 28.
    Zatzick DF, Jurkovich GJ, Fan M-Y, Grossman D, Russo J, Katon W. Association between posttraumatic stress and depressive symptoms and functional outcomes in adolescents followed up longitudinally after injury hospitalization. Arch Pediatr Adolesc Med. 2008;162(7):642–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Miller VA, Feudtner C, Jawad AF. Children’s decision-making involvement about research participation: associations with perceived fairness and self-efficacy. J Empir Res Hum Res Ethics. 2017;12(1):6–13.PubMedCrossRefGoogle Scholar
  30. 30.
    Rose CD. Ethical conduct of research in children: pediatricians and their IRB (Part 2 of 2). Pediatrics. 2017;139(6):pii: e20163650. Scholar
  31. 31.
    Etchells E, Darzins P, Silberfeld M, Singer PA, McKenny J, Naglie G, Katz M, Guyatt GH, Molloy DW, Strang D. Assessment of patient capacity to consent to treatment. J Gen Intern Med. 1999;14(1):27–34.PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    Reynolds S, Grant-Kels JM, Bercovitch L. How issues of autonomy and consent differ between children and adults: kids are not just little people. Clin Dermatol. 2017;35(6):601–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Wilson JMG, Jonner G. Principles and practice of screening for disease. Geneva: World Health Organization; 1968.Google Scholar
  34. 34.
    Rogers WA, Craig WL, Entwistle VA. Ethical issues raised by thyroid cancer overdiagnosis: a matter for public health? Bioethics. 2017;31(8):590–8.PubMedCrossRefGoogle Scholar
  35. 35.
    SHAMISEN. ST1—Lessons learned from dosimetric and health screening, evacuation and health surveillance: executive summary. 2017. Accessed 21 Jan 2017.

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Department of Radiation Health ManagementFukushima Medical UniversityFukushimaJapan

Personalised recommendations